207 related articles for article (PubMed ID: 21337005)
1. When MAGE meets RING: insights into biological functions of MAGE proteins.
Feng Y; Gao J; Yang M
Protein Cell; 2011 Jan; 2(1):7-12. PubMed ID: 21337005
[TBL] [Abstract][Full Text] [Related]
2. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.
Doyle JM; Gao J; Wang J; Yang M; Potts PR
Mol Cell; 2010 Sep; 39(6):963-74. PubMed ID: 20864041
[TBL] [Abstract][Full Text] [Related]
3. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.
Kozakova L; Vondrova L; Stejskal K; Charalabous P; Kolesar P; Lehmann AR; Uldrijan S; Sanderson CM; Zdrahal Z; Palecek JJ
Cell Cycle; 2015; 14(6):920-30. PubMed ID: 25590999
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.
Lee AK; Potts PR
J Mol Biol; 2017 Apr; 429(8):1114-1142. PubMed ID: 28300603
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of the MAGE protein family in stress response pathways.
Florke Gee RR; Chen H; Lee AK; Daly CA; Wilander BA; Fon Tacer K; Potts PR
J Biol Chem; 2020 Nov; 295(47):16121-16155. PubMed ID: 32921631
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases.
Yang SW; Huang X; Lin W; Min J; Miller DJ; Mayasundari A; Rodrigues P; Griffith EC; Gee CT; Li L; Li W; Lee RE; Rankovic Z; Chen T; Potts PR
Nat Commun; 2020 Oct; 11(1):4931. PubMed ID: 33004795
[TBL] [Abstract][Full Text] [Related]
7. MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
Marcar L; Ihrig B; Hourihan J; Bray SE; Quinlan PR; Jordan LB; Thompson AM; Hupp TR; Meek DW
PLoS One; 2015; 10(5):e0127713. PubMed ID: 26001071
[TBL] [Abstract][Full Text] [Related]
8. MAGED1: molecular insights and clinical implications.
Wang X; Gao X; Xu Y
Ann Med; 2011 Aug; 43(5):347-55. PubMed ID: 21612333
[TBL] [Abstract][Full Text] [Related]
9. The MAGE protein family and cancer.
Weon JL; Potts PR
Curr Opin Cell Biol; 2015 Dec; 37():1-8. PubMed ID: 26342994
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs.
Lian Y; Meng L; Ding P; Sang M
Clin Epigenetics; 2018 Sep; 10(1):115. PubMed ID: 30185218
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity of the MAGE family.
Li S; Shi X; Li J; Zhou X
Oncol Lett; 2021 Dec; 22(6):844. PubMed ID: 34733362
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific MAGE proteins as regulators of p53 function.
Ladelfa MF; Peche LY; Toledo MF; Laiseca JE; Schneider C; Monte M
Cancer Lett; 2012 Dec; 325(1):11-7. PubMed ID: 22664239
[TBL] [Abstract][Full Text] [Related]
13. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
[TBL] [Abstract][Full Text] [Related]
14. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.
Sasaki A; Masuda Y; Iwai K; Ikeda K; Watanabe K
J Biol Chem; 2002 Jun; 277(25):22541-6. PubMed ID: 11959851
[TBL] [Abstract][Full Text] [Related]
15. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.
Hao J; Song X; Wang J; Guo C; Li Y; Li B; Zhang Y; Yin Y
Oncotarget; 2015 Dec; 6(39):42028-39. PubMed ID: 26540345
[TBL] [Abstract][Full Text] [Related]
16. Biological functions of melanoma-associated antigens.
Xiao J; Chen HS
World J Gastroenterol; 2004 Jul; 10(13):1849-53. PubMed ID: 15222021
[TBL] [Abstract][Full Text] [Related]
17. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
[TBL] [Abstract][Full Text] [Related]
18. Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
Newman JA; Cooper CD; Roos AK; Aitkenhead H; Oppermann UC; Cho HJ; Osman R; Gileadi O
PLoS One; 2016; 11(2):e0148762. PubMed ID: 26910052
[TBL] [Abstract][Full Text] [Related]
19. MAGE-A family: attractive targets for cancer immunotherapy.
Sang M; Lian Y; Zhou X; Shan B
Vaccine; 2011 Nov; 29(47):8496-500. PubMed ID: 21933694
[TBL] [Abstract][Full Text] [Related]
20. Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.
Collins RRJ; Gee RRF; Sanchez MCH; Tozandehjani S; Bayat T; Breznik B; Lee AK; Peters ST; Connelly JP; Pruett-Miller SM; Roussel MF; Rakheja D; Tillman HS; Potts PR; Fon Tacer K
bioRxiv; 2024 May; ():. PubMed ID: 38798351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
